Sinocelltech Group Limited (SHA:688520)
34.16
+0.98 (2.95%)
Jun 18, 2026, 3:00 PM CST
Sinocelltech Group Market Cap
Sinocelltech Group has a market cap or net worth of 16.07 billion as of June 18, 2026. Its market cap has decreased by -10.10% in one year.
Market Cap
16.07B
Enterprise Value
17.63B
Revenue
1.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
34.16
Market Cap Chart
Since June 22, 2020, Sinocelltech Group's market cap has decreased from 31.81B to 16.07B, a decrease of -49.49%. That is a compound annual growth rate of -10.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 16.07B | -16.70% |
| Dec 31, 2025 | 19.29B | 19.54% |
| Dec 31, 2024 | 16.13B | -32.75% |
| Dec 29, 2023 | 23.99B | -11.11% |
| Dec 30, 2022 | 26.99B | 6.06% |
| Dec 31, 2021 | 25.45B | 28.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 23.74B |
| Hualan Biological Engineering | 23.46B |
| Xiamen Amoytop Biotech | 22.79B |
| BrightGene Bio-Medical Technology | 18.81B |
| Yili Chuanning Biotechnology | 18.78B |
| Chengdu Olymvax Biopharmaceuticals | 14.48B |
| Jinyu Bio-technology | 12.86B |
| Anhui Anke Biotechnology (Group) | 12.79B |